About

In his role at Scion, Alec has hands-on knowledge of working with New Zealand companies to create, manufacture and use bioproducts. Before joining our team, he led one of Europe's largest synthetic biology programmes, developing new materials with genetically engineered microorganisms. With more than 40 patents and experience with world-leading biotech companies, Alec brings a unique insight into the science, materials and technologies of the future.

In October 2022, he was appointed to BioTechNZ’s Executive Council for a two-year term.